严重毒副反应发生率低于10%。
主要毒副反应为骨髓抑制和静脉炎。
未出现严重早和晚反应放射毒副反应。
No serious acute and late radiation reactions have been encountered.
主要毒副反应为发热和皮疹。
主要的毒副反应为血液毒性。
肺腺癌；易瑞沙；毒副反应；治疗结果。
Lung neoplasm; Iressa; Toxicity reaction; Treatment outcome.
主要毒副反应为胃肠道反应和骨髓抑制。
The major side effects were gastrointestinal reaction and suppression of bone marrow.
毒副反应主要为骨髓抑制。
感染、出血等毒副反应发生率低、反应轻。
The incidence of infection and hemorrhage was low and slight.
观察拓朴替康治疗小细胞肺癌的疗效和毒副反应。
To observe the effect and toxicity of topotecan in the treatment for small cell lung cancer(SCLC).
结果44例患者能积极配合治疗，治疗的毒副反应低，疗效好。
Results: 44 patients could cooperate during treatment and had low tox-side reaction but good therapeutic effect.
观察两组患者毒副反应发生率、消化道反应以及生活质量情况。
Incidence of toxic and adverse reaction, digestive tract reaction and quality of life in patients of two groups were observed.
主要毒副反应为骨髓抑制、胃肠道反应、周围神经毒性及静脉炎。
The main side effects were myelosuppresion, gastrointestinal reation and peripheral nerve toxicity and phlebitis.
主要毒副反应为发热、战、闷、过性皮疹及短暂的肝功能指标升高等。
The major toxicities were fever chill tire tetter transitory abnormal liver function and so on.
主要毒副反应为发热、战、闷、过性皮疹及短暂的肝功能指标升高等。
The major toxicities were fever, chill, tire, tetter, transitory abnormal liver function and so on.
目的观察腹腔化疗联合静脉化疗治疗晚期胃癌的临床疗效及毒副反应。
Objective to observe the therapeutic efficacy and side effects of intraperitoneal chemotherapy combined with intravenous chemotherapy.
目的观察伊立替康联合奈达铂二线治疗小细胞肺癌的疗效及毒副反应。
Objective To evaluate the efficacy and toxicity of irinotecan combined with nedaplatin in second-line therapy of small-cell lung cancer.
复方苦参注射液可明显降低化疗药物的毒副反应，提高患者的生活质量。
Composite Sophorae Injection can reduce the toxicity and adverse effects caused by chemotherapy medicine, and improve quality of life.
目的观察紫杉醇联合顺铂治疗远处转移的晚期鼻咽癌的疗效和毒副反应。
Objective to observe the efficacy and toxicities of paclitaxel combined with DDP in treatment of advanced nasopharyngeal carcinoma.
目的：观察国产多烯紫杉醇联合顺铂治疗晚期乳腺癌的疗效及毒副反应。
Objective: to observe the effects and toxicity of docetaxel plus DDP in treatment of advanced breast cancer.
目的：综述雷公藤作为免疫抑制剂在临床上的毒副反应及临床减毒方法。
Objective: to review Tripterygium Wifordii as immunosuppressant in the clinical toxicity and clinical attenuated method.
结论平消胶囊可以配合化疗治疗消化系恶性肿瘤，提高疗效，减轻毒副反应。
Conclusion Pingxiao Capsule can be combined with chemotherapy in the treatment of malignant tumors in digestive system, improve efficacy, reduce the toxicity.
主要毒副反应为发热、 战、 闷、 过性皮疹及短暂的肝功能指标升高等。
The major toxicities were fever, chill, tire, tetter , transitory abnormal liver function and so on.
结论改良的FOLFOX 4方案治疗晚期大肠癌疗效较高，毒副反应可耐受。
Conclusions The modified FOLFOX4 regimen is highly effective and well tolerated in treatment of advanced colorectal cancer.
分子靶向治疗比传统的化疗特异性强、毒副反应小，将成为今后肿瘤治疗的新趋势。
Molecular targeted therapy has limited or nonexistent side effects on normal cells of the body, unlike traditional chemotherapy.
目的：评价动脉灌注化疗联合热疗治疗中晚期非小细胞肺癌的临床疗效和毒副反应。
Objective: To evaluate the efficacy and side effects of transcatheter arterial infusion chemotherapy and hyperthermia in the treatment of mid and advanced non-small cell lung cancer.
为此，本研究探讨加速分割放疗同步卡培他滨化疗治疗晚期鼻咽癌的疗效和毒副反应。
In this study, the efficacy and toxicity of accelerated fractionated radiotherapy with concurrent capecitabin chemotherapy for advanced NPC were investigated.
目的：对比观察得力生注射液与NP方案治疗晚期非小细胞肺癌的临床疗效和毒副反应。
Objective: To compare the clinic effect and the adverse effect of Delisheng injection with NP regimen in advanced non-small cell lung cancer (NSCLC).
目的：对比观察得力生注射液与NP方案治疗晚期非小细胞肺癌的临床疗效和毒副反应。
Objective: To compare the clinic effect and the adverse effect of Delisheng injection with NP regimen in advanced non-small cell lung cancer (NSCLC).
应用推荐